Please assess the completion status of the following clinical trial:

Trial Title: A Midazolam Drug Interaction Study With PF-04171327

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy males and/or females (non-childbearing potential) volunteers.~* Cortisol level within normal reference range of the laboratory.~Exclusion Criteria:~* History of intolerance or significant adverse effect with glucocorticoid (steroid) therapy.~* History or current positive results for HIV, Hepatitis B or C or active TB or currently undergoing treatment for TB.~* Known history of hypersensitivity, allergy severe drug reaction or unable to tolerate midazolam or other benzodiazepines.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- PF-04171327 and Midazolam (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).